Literature DB >> 977761

Serial liver biopsies in blood donors with persistent HBs antigenaemia.

E Tapp, D M Jones, D Hollanders, I W Dymock.   

Abstract

Initial liver biopsies from asymptomatic HBs antigen positive blood donors showed a range of histological abnormalities ranging from minor parenchymal lesions to cirrhosis. Twenty of these have now been followed up for periods of up to four years and during that time have had at least two liver biopsies. Throughout the period of study all the donors have remained carriers of HBs Ag, and there was no significant variation in the titers of antigen or the electron microscopic appearances of the serum in individual donors. The histological appearances of subsequent liver biopsies were not always the same as those seen initially, and while there appeared to be some improvement in three cases, there were nine in which the histological appearances were worse.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 977761      PMCID: PMC476206          DOI: 10.1136/jcp.29.10.884

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  Needle biopsy of the liver in cirrhosis; diagnostic efficiency as determined by postmortem sampling.

Authors:  H BRAUNSTEIN
Journal:  AMA Arch Pathol       Date:  1956-08

Review 2.  Liver biopsy in the diagnosis of cirrhosis.

Authors:  P J Scheuer
Journal:  Gut       Date:  1970-03       Impact factor: 23.059

3.  Asymptomatic hapatic disease in blood donors with hepatitis B antigenemia.

Authors:  S B Vittal; D Dourdourekas; N Shobassy; M Gerber; M Telischi; P B Szanto; F Steigmann; B F Clowdus
Journal:  Am J Clin Pathol       Date:  1974-11       Impact factor: 2.493

4.  Natural history of hepatitis-associated antigen-positive chronic liver disease.

Authors:  F J Dudley; P J Scheuer; S Sherlock
Journal:  Lancet       Date:  1972-12-30       Impact factor: 79.321

5.  Australia antigen and antibody in 10,000 Danish blood-donors.

Authors:  O Banke; E Dybkjaer; E Nordenfelt; V Reinicke
Journal:  Lancet       Date:  1971-04-24       Impact factor: 79.321

6.  Liver disease in Australia-antigen-positive blood-donors.

Authors:  J W Singleton; D A Merrill; R A Fitch; P F Kohler; W A Rettberg
Journal:  Lancet       Date:  1971-10-09       Impact factor: 79.321

7.  Asymptomatic liver disease in hepatitis B antigen carriers.

Authors:  I L Woolf; B E Boyes; D M Jones; J S Whittaker; E Tapp; R N MacSween; P H Renton; F Stratton; I W Dymock
Journal:  J Clin Pathol       Date:  1974-05       Impact factor: 3.411

8.  A study of Australia-antigen-positive blood donors and their recipients, with special reference to liver histology.

Authors:  V Reinicke; E Dybkjaer; H Poulsen; O Banke; K Lylloff; E Nordenfelt
Journal:  N Engl J Med       Date:  1972-04-20       Impact factor: 91.245

9.  Morphologic and etiologic diagnoses from hepatic biopsies without clinical data.

Authors:  A H Baggenstoss
Journal:  Medicine (Baltimore)       Date:  1966-11       Impact factor: 1.889

10.  Liver disease and cell-mediated immunity in hepatitis-associated antigen (HAA) carriers.

Authors:  T D Bolin; A E Davis; A G Liddelow
Journal:  Gut       Date:  1973-05       Impact factor: 23.059

  10 in total
  6 in total

Review 1.  Natural history of the HBsAg carrier.

Authors:  M G Anderson; I M Murray-Lyon
Journal:  Gut       Date:  1985-08       Impact factor: 23.059

2.  HBsAg and HBcAg in the livers of asymptomatic hepatitis B antigen carriers.

Authors:  E Tapp; D M Jones
Journal:  J Clin Pathol       Date:  1977-07       Impact factor: 3.411

3.  Specialty conference: Chronic hepatitis B.

Authors: 
Journal:  West J Med       Date:  1978-04

4.  Should chronic HBV infected patients with normal ALT treated: debate.

Authors:  Shiv Kumar Sarin; Manoj Kumar
Journal:  Hepatol Int       Date:  2008-03-04       Impact factor: 6.047

5.  Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

Authors:  S K Sarin; M Kumar; G K Lau; Z Abbas; H L Y Chan; C J Chen; D S Chen; H L Chen; P J Chen; R N Chien; A K Dokmeci; Ed Gane; J L Hou; W Jafri; J Jia; J H Kim; C L Lai; H C Lee; S G Lim; C J Liu; S Locarnini; M Al Mahtab; R Mohamed; M Omata; J Park; T Piratvisuth; B C Sharma; J Sollano; F S Wang; L Wei; M F Yuen; S S Zheng; J H Kao
Journal:  Hepatol Int       Date:  2015-11-13       Impact factor: 6.047

Review 6.  DNA-guided hepatitis B treatment, viral load is essential, but not sufficient.

Authors:  Rafael Bárcena Marugán; Silvia García Garzón
Journal:  World J Gastroenterol       Date:  2009-01-28       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.